Haemophilus influenza (Hib) diseases
Haemophilus influenzae type b (Hib) is estimated to cause millions of cases of serious disease worldwide and hundreds of thousands of deaths each year among young children. The main clinical manifestations of invasive Hib infections include severe pneumonia and meningitis. Hib vaccines are the only public health tool capable of preventing the majority of cases of serious Hib disease; and in view of their demonstrated safety and efficacy, WHO recommends including conjugate Hib vaccines in all routine infant immunization programmes.
Top storySlovakia raises awareness about vaccination
A new publication on vaccination in Slovakia and the European Union was launched at the start of the Slovak Presidency of the Council of the European Union this month to educate experts, health workers and the general public on the importance of vaccination in preventing serious diseases.
- Education of health workers on vaccine safety and contraindications against vaccination in 7 countries
- European Immunization Week in the classroom
- Immunize Europe Forum: a new online resource for the immunization community
WHO_Europe_VPI twitter feed
European Immunization Week
Each year in April, EIW promotes the core message that the immunization of every child is vital to prevent diseases and protect life. The goal of the region-wide campaign is to increase vaccination coverage by raising awareness of the importance of immunization. EIW 2017 will be celebrated on 24–30 April.This year's campaign
Data and statistics
Although the age-specific incidence and type of disease vary in different parts of the world, statistics show that about 80% of invasive Hib disease occurs before the age of 5 in all locations.More data and statistics
PublicationsTailoring immunization programmes (TIP) evaluation report More TIP publications and country projects
Immunize Europe Forum
WHO/Europe is proud to announce the launch of a new online resource for the immunization communityVisit the Forum